Hepatobiliary Carcinoma in Situ clinical trials at UC Irvine
1 research study open to eligible people
Showing trials for
Ph II Intraperitoneal Paclitaxel + System Therapy in GI Ca w/Peritoneal Carcinomatosis (STOPGAP-B)
open to eligible people ages 18 years and up
This is a phase II open-label, basket clinical trial to assess the feasibility of systemic and Intraperitoneal chemotherapy in subjects with Gastrointestinal Malignancies with Peritoneal Carcinomatosis. These are subjects who have a proven primary carcinoma of the digestive tract..
Orange, California
Our lead scientists for Hepatobiliary Carcinoma in Situ research studies include Maheswari Senthil, MD.
Last updated: